Effect of Dacarbazine Chemotherapy in Well-Differentiated Neuroendocrine Tumors

被引：0
作者：
Mueller, D. [1 ]
Rinke, A. [1 ]
Gress, T. [1 ]
机构：
[1] Univ Marburg, Dept Internal Med, Div Gastroenterol & Endocrinol, D-3550 Marburg, Germany
来源：
NEUROENDOCRINOLOGY | 2012年 / 96卷
关键词：
neuroendocrine tumor; chemotherapy; dacarbazine;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：50 / 50
页数：1
相关论文
共 50 条
[21]   Molecular Pathology of Well-Differentiated Gastro-entero-pancreatic Neuroendocrine Tumors [J].
Sylvia L. Asa ;
Stefano La Rosa ;
Olca Basturk ;
Volkan Adsay ;
Marianna Minnetti ;
Ashley B. Grossman .
Endocrine Pathology, 2021, 32 :169-191
[22]   The Problem of High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms Well-Differentiated Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Beyond [J].
Sorbye, Halfdan ;
Baudin, Eric ;
Perren, Aurel .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2018, 47 (03) :683-+
[23]   Primary Well-Differentiated Neuroendocrine Tumor of the Kidney [J].
Prasad, Vishnu ;
Sreelakshmi, Charakkulam Vijay ;
Chandran, K. Ravi ;
Agrawal, Shashank ;
Pooleri, Ginil Kumar ;
Sao, Amrita .
JOURNAL OF KIDNEY CANCER AND VHL, 2023, 10 (02) :8-12
[24]   A well-differentiated neuroendocrine tumor of the left kidney [J].
Jiang, Hongyan ;
Yang, Ling ;
Luo, Ting ;
Zhao, Yunfei .
ASIAN JOURNAL OF SURGERY, 2024, 47 (12) :5414-5415
[25]   Management of Well-Differentiated High-Grade (G3) Neuroendocrine Tumors [J].
Mohamad Bassam Sonbol ;
Thorvardur R. Halfdanarson .
Current Treatment Options in Oncology, 2019, 20
[26]   Comparison of Methods for Proliferative Index Analysis for Grading Pancreatic Well-Differentiated Neuroendocrine Tumors [J].
Goodell, Pamela P. ;
Krasinskas, Alyssa M. ;
Davison, Jon M. ;
Hartman, Douglas J. .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 137 (04) :576-582
[27]   Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors [J].
P. Jiménez-Fonseca ;
A. Carmona-Bayonas ;
E. Martín-Pérez ;
G. Crespo ;
R. Serrano ;
M. Llanos ;
C. Villabona ;
R. García-Carbonero ;
J. Aller ;
J. Capdevila ;
E. Grande .
Cancer and Metastasis Reviews, 2015, 34 :381-400
[28]   Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors [J].
Jimenez-Fonseca, P. ;
Carmona-Bayonas, A. ;
Martin-Perez, E. ;
Crespo, G. ;
Serrano, R. ;
Llanos, M. ;
Villabona, C. ;
Garcia-Carbonero, R. ;
Aller, J. ;
Capdevila, J. ;
Grande, E. .
CANCER AND METASTASIS REVIEWS, 2015, 34 (03) :381-400
[29]   Treatment modalities favoring outcome in well-differentiated neuroendocrine tumors G3 [J].
Hinterleitner, Martina ;
Pfeiffer, Ruben ;
Trautwein, Nils F. ;
Sipos, Bence ;
Singer, Stephan ;
Nadalin, Silvio ;
Koenigsrainer, Alfred ;
Lauer, Ulrich M. ;
la Fougere, Christian ;
Zender, Lars ;
Hinterleitner, Clemens .
FRONTIERS IN ENDOCRINOLOGY, 2024, 14
[30]   Plasma Neurokinin A Levels Predict Survival in Well-Differentiated Neuroendocrine Tumors of the Small Bowel [J].
Woltering, Eugene A. ;
Voros, Brianne A. ;
Thiagarajan, Ramcharan ;
Beyer, David T. ;
Ramirez, Robert A. ;
Wang, Yi-Zarn ;
Mamikunian, Gregg ;
Boudreaux, J. Philip .
PANCREAS, 2018, 47 (07) :843-848
12345